Accessibility links

Breaking News

Peru to Host Clinical Trials for Coronavirus Vaccine


Images of the 125 doctors who have died during the COVID-19 pandemic in Peru, are displayed outside Peru's Medical College (CMP) in Lima on Aug. 13, 2020.
Images of the 125 doctors who have died during the COVID-19 pandemic in Peru, are displayed outside Peru's Medical College (CMP) in Lima on Aug. 13, 2020.

China's Sinopharm Laboratory will begin human clinical trials for a possible vaccine against COVID-19 in Peru on Monday.

Peruvian President Martin Vizcarra announced Thursday that 6,000 volunteers will participate in the trials.

Vizcarra expects a second clinical trial, by the firm AstraZeneca in association with Oxford University, will begin by the end of August.

Vizcarra said Peru will be part of the World Health Organization initiative to vaccinate at least 20% of the global population, which would mean around 6.6 million Peruvians.

So far, Peru has reported more than 560,000 coronavirus cases and more than 27,000 deaths.

  • 16x9 Image

    VOA News

    The Voice of America provides news and information in more than 40 languages to an estimated weekly audience of over 326 million people. Stories with the VOA News byline are the work of multiple VOA journalists and may contain information from wire service reports.

XS
SM
MD
LG